SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development

Immunity

Volumn 8, Issue 5, 1998, Pages 625-634

  Swat, Wojciech ^a,b   Fujikawa, Keiko ^b   Ganiatsas, Soula ^a   Yang, Di ^d   Xavier, Ramnik J ^b   Harris, Nancy L ^b   Davidson, Laurie ^a   Ferrini, Roger ^a   Davis, Roger J ^e   Labow, Mark A ^f   Flavell, Richard A ^d   Zon, Leonard I ^a,c   Alt, Frederick W ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE; PROTEIN KINASE SAPK; PROTEIN KINASE SEK 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BLASTOCYST; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVATION; LYMPHADENOPATHY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PLASMACYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 17344375955     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80567-1     Document Type: Article

References (66)

1. Berberich, I., Shu, G., Siebelt, F., Woodgett, J.R., Kyriakis, J.M., and Clark, E.A. (1996). Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J. 15, 92-101.
2. Bories, J.C., Willerford, D.M., Grevin, D., Davidson, L., Camus, A., Martin, P., Stehelin, D., and Alt, F.W. (1995). Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 19, 635-638.
3. Brandt, S.J., Bodine, D.M., Dunbar, C.E., and Nienhuis, A.W. (1990). Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J. Clin. Invest. 86, 592-599.
4. Cacalano, G., Lee, J., Kikly, K., Ryan, A.M., Pitts-Meek, S., Hultgren, B., Wood, W.I., and Moore, M.W. (1994). Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265, 682-684.
5. Chambers, C.A., Cado, D., Truong, T., and Allison, J.P. (1997). Thymocyte development is normal in CTLA-4-deficient mice. Proc. Natl. Acad. Sci. USA 94, 9296-9301.
6. Chan, V.W., Meng, F., Soriano, P., DeFranco, A.L., and Lowell, C.A. (1997). Characterization of the B lymphocyte populations in Lyndeficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7, 69-81.
7. Chauhan, D., Kharbanda, S., Ogata, A., Urashima, M., Teoh, G., Robertson, M., Kufe, D.W., and Anderson, K.C. (1997). Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood 89, 227-234.
8. Chen, J., and Alt, F.W. (1994). RAG-deficient blastocyst complementation. In Transgenesis and Targeted Mutagenesis in Immunology, H. Bluethmann and P. Ohashi, eds. (New York: Academic Press), pp. 35-49.
9. Chen, J., Lansford, R., Stewart, V., Young, F., and Alt, F.W. (1993). RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. Proc. Natl. Acad. Sci. USA 90, 4528-4532.
10. Cohen, P.L., and Eisenberg, R.A. (1991). Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9, 243-269.
11. Coso, O.A., Chiariello, M., Yu, J.C., Teramoto, H., Crespo, P., Xu, N., Miki, T., and Gutkind, J.S. (1995). The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81, 1137-1146.
12. Cosulich, S., and Clarke, P. (1996). Apoptosis: does stress kill? Curr. Biol. 6, 1586-1588.
13. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P.G., Coso, O.A., Gutkind, S., and Spiegel, S. (1996). Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381, 800-803.
14. Davis, R.J. (1993). The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268, 14553-14556.
15. Derijard, B., Hibi, M., Wu, I.H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R.J. (1994). JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylatesthec-Jun activation domain. Cell 76, 1025-1037.
16. Fanger, G.R., Gerwins, P., Widmann, C., Jarpe, M.B., and Johnson, G.L. (1997). MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr. Opin. Genet. Dev. 7, 67-74.
17. Fisher, A.G., Bürdet, C., LeMeur, M., Haasner, D., Gerber, P., and Ceredig, R. (1993). Lymphoproliferative disorders in an IL-7 transgenic mouse line. Leukemia 7, Suppl. 2, S66-S68.
18. Ganiatsas, S., Kwee, L., Fujiwara, Y., Perkins, A., Ikeda, T., Labow, M.A., and Zon, L.I. (1998). SEK1 deficiency reveals MAPK cascade cross-regulation and leads to abnormal hepatogenesis. Proc. Natl. Acad. Sci. USA, in press.
19. Goedert, M., Cuenda, A., Craxton, M., Jakes, R., and Cohen, P. (1997). Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO J. 16, 3563-3571.
20. Goillot, E., Raingeaud, J., Ranger, A., Tepper, R.I., Davis, RJ., Har-low, E., and Sanchez, I. (1997). Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc. Natl. Acad. Sei. USA 94, 3302-3307.
21. Graves, J.D., Graves, K.E., Craxton, A., Saklatvala, J., Krebs, E.G. and Clark, E.A. (1996). Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mlgM-induced apoptosis of human B lymphocytes. Proc. Natl. Acad. Sci. USA 93, 13814-13818.
22. Hibbs, M.L., Tarlinton, D.M., Armes, J., Grail, D., Hodgson, G., Maglitto, R., Stacker, S.A., and Dunn, A.R. (1995). Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83, 301-311.
23. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. (1993). Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7, 2135-2148.
24. Holland, P.M., Suzanne, M., Campbell, J.S., Noselli, S., and Cooper, J.A. (1997). MKK7 is a stress-activated mitogen-activated protein kinase kinase functionally related to hemipterous. J. Biol. Chem. 272, 24994-24998.
25. Kawakami, Y., Miura, T., Bissonnette, R., Hata, D., Khan, W.N., Kitamura, T., Maeda-Yamamoto, M., Hartman, S.E., Yao, L., Alt, F.W., et al. (1997). Bruton's tyrosine kinase regulates apoptosis and JNK/ SAPK kinase activity. Proc. Natl. Acad. Sci. USA 94, 3938-3942.
26. Kiefer, F., Tibbles, L.A., Lassam, N., Zanke, B., Iscove, N., and Woodgett, J.R. (1997). Novel components of mammalian stress-activated protein kinase cascades. Biochem. Soc. Trans. 25, 491-498.
27. Koyasu, S., Hussey, R.E., Clayton, L.K., Lerner, A., Pedersen, R., Delany-Heiken, P., Chau, F., and Reinherz, E.L. (1994). Targeted disruption within the CDS zeta/eta/phi/Oct-1 locus in mouse. EMBO J. 13, 784-797.
28. Kyriakis, J.M., and Avruch, J. (1996). Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18, 567-577.
29. Latinis, K.M., and Koretzky, G.A. (1996). Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood 87, 871-875.
30. Lenczowski, J.M., Dominguez, L., Eder, A.M., King, L.B., Zacharchuk, C.M., and Ashwell, J.D. (1997). Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol. Cell. Biol. 17, 170-181.
31. Liu, Z.G., Hsu, H., Goeddel, D.V., and Karin, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87, 565-576.
32. Marshall, C.J. (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185.
33. McDonnell, T.J., Deane, N., Platt, F.M., Nunez, G., Jaeger, U., McKearn, J.P., and Korsmeyer, S.J. (1989). bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57, 79-88.
34. McDonnell, T.J., Nunez, G., Platt, F.M., Hockenberry, D., London, L., McKearn, J.P., and Korsmeyer, S.J. (1990). Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol. Cell. Biol. 10, 1901-1907.
35. Muthusamy, N., Barton, K., and Leiden, J.M. (1995). Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 377, 639-642.
36. Nagata, S. (1994). Fas and Fas ligand: a death factor and its receptor. Adv. Immunol. 57, 129-144.
37. Nishina, H., Fischer, K.D., Radvanyi, L., Shahinian, A., Hakem, R., Rubie, E.A., Bernstein, A., Mak, T.W., Woodgett, J.R., and Penninger, J.M. (1997a). Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CDS. Nature 385, 350-353.
38. Nishina, H., Bachmann, M., Oliveira-dos-Santos, A.J., Kozieradzki, I., Fischer, K.D., Odermatt, B., Wakeham, A., Shahinian, A., Takimoto, H., Bernstein, A., et al. (1997b). Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes. J. Exp. Med. 86, 941-953.
39. Nishizumi, H., Taniuchi, I., Yamanashi, Y., Kitamura, D., Ilic, D., Mori, S., Watanabe, T., and Yamamoto, T. (1995). Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyndeficient mice. Immunity 3, 549-560.
40. Ohno, H., Goto, S., Taki, S., Shirasawa, T., Nakano, H., Miyatake, S., Aoe, T., Ishida, Y., Maeda, H., Shirai, T., et al. (1994). Targeted disruption of the CDS eta locus causes high lethality in mice: modulation of Oct-1 transcription on the opposite strand. EMBO J. 13, 1157-1165.
41. Rich, B.E., Campos-Torres, J., Tepper, R.I., Moreadith, R.W., and Leder, P. (1993). Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J. Exp. Med. 177, 305-316.
42. Rincon, M., and Flavell, R.A. (1994). AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 13, 4370-4381.
43. Sadlack, B., Kuhn, R., Schorle, H., Rajewsky, K., Muller, W., and Horak, I. (1994). Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur. J. Immunol. 24, 281-284.
44. + T cells. Eur. J. Immunol. 25, 3053-3059.
45. Sanchez, I., Hughes, R.T., Mayer, B.J., Yee, K., Woodgett, J.R., Avruch, J., Kyriakis, J.M., and Zon, L.I. (1994). Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372, 794-798.
46. Screpanti, I., Romani, L., Musiani, P., Modesti, A., Fattori, E., Lazzaro, D., Sellitto, C., Scarpa, S., Bellavia, D., Lattanzio, G., et al. (1995). Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J. 14, 1932-1941.
47. Shultz, L.D., and Green, M.C. (1976). Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins. J. Immunol. 116, 936-943.
48. Shultz, L.D., Coman, D.R., Bailey, C.L., Beamer, W.G., and Sidman, C.L. (1984). "Viable motheaten," a new allele at the motheaten locus: I. pathology. Am. J. Pathol. 116, 179-192.
49. Strasser, A., Harris, A.W., Vaux, D.L., Webb, E., Bath, M.L., Adams, J.M., and Cory, S. (1990). Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr. Top. Microbiol. Immunol. 166, 175-181.
50. Strasser, A., Whittingham, S., Vaux, D.L., Bath, M.L., Adams, J.M., Cory, S., and Harris, A.W. (1991). Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 88, 8661-8665.
51. Su, B., and Karin, M. (1996). Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 8, 402-411.
52. Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M., and Ben-Neriah, Y. (1994). JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77, 727-736.
53. Tepper, R.I., Levinson, D.A., Stanger, B.Z., Campos-Torres, J., Abbas, A.K., and Leder, P. (1990). IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 62, 457-467.
54. Tivol, E.A., Borriello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A., and Sharpe, A.H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
55. Tournier, C., Whitmarsh, A.J., Cavanagh, J., Barrett, T., and Davis, R.J. (1997). Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc. Natl. Acad. Sci. USA 94, 7337-7342.
56. Treisman, R. (1996). Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8, 205-215.
57. Verheij, M., Bose, R., Lin, X.H., Yao, B., Jarvis, W.D., Grant, S., Birrer, M.J., Szabo, E., Zon, L.I., Kyriakis, J.M., et al. (1996). Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380, 75-79.
58. Wang, J., Koizumi, T., and Watanabe, T. (1997). Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice. J. Exp. Med. 184, 831-838.
59. Waterhouse, P., Penninger, J.M., Timms, E., Wakeham, A., Shahinian, A., Lee, K.P., Thompson, C.B., Griesser, H., and Mak, T.W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988.
60. Willerford, D.M., Chen, J., Ferry, J.A., Davidson, L., Ma, A., and Alt, F.W. (1995). Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521-530.
61. Wu, Z., Wu, J., Jacinto, E., and Karin, M. (1997). Molecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase-specific kinase. Mol. Cell. Biol. 17, 7407-7416.
62. Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., and Greenberg, M.E. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
63. Yang, D., Tournier, C., Wysk, M., Lu, H.T., Xu, J., Davis, R.J., and Flavell, R.A. (1997). Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc. Natl. Acad. Sci. USA 94, 3004-3009.
64. Yang, X., Khosravi-Far, R., Chang, H.Y., and Baltimore, D. (1997). Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89, 1067-1076.
65. Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., Komori, T., et al. (1989). Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74, 1360-1367.
66. Zanke, B.W., Boudreau, K., Rubie, E., Winnett, E., Tibbles, L.A., Zon, L., Kyriakis, J., Liu, F.F., and Woodgett, J.R. (1996). The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr. Biol. 6, 606-613.